spironolactone has been researched along with Angioma, Cavernous in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Angioma, Cavernous: A tumor-like mass with large vascular space that is filled with blood or lymph.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howell, DM | 1 |
| Gumbiner, CH | 1 |
| Martin, GE | 1 |
1 other study available for spironolactone and Angioma, Cavernous
| Article | Year |
|---|---|
Congestive heart failure due to giant cutaneous cavernous hemangioma.
Topics: Digoxin; Drug Resistance; Facial Neoplasms; Female; Furosemide; Heart Failure; Hemangioma, Cavernous | 1984 |